Filter Results:
(197)
Show Results For
- All HBS Web
(433)
- People (1)
- News (138)
- Research (197)
- Events (3)
- Multimedia (2)
- Faculty Publications (83)
Show Results For
- All HBS Web
(433)
- People (1)
- News (138)
- Research (197)
- Events (3)
- Multimedia (2)
- Faculty Publications (83)
Sort by
- March 2014
- Article
Delivering High-quality Cancer Care: The Critical Role of Quality Measurement
By: Tracy Spinks, Patricia Ganz, George Sledge, Laura Levit, James Hayman, Timothy Eberlein and Thomas W. Feeley
In 1999, the Institute of Medicine (IOM) published Ensuring Quality Cancer Care, an influential report that described an ideal cancer care system and issued ten recommendations to address pervasive gaps in the understanding and delivery of quality cancer... View Details
Keywords: Health Care Quality; Health Care and Treatment; Quality; Measurement and Metrics; Health Industry; North America
Spinks, Tracy, Patricia Ganz, George Sledge, Laura Levit, James Hayman, Timothy Eberlein, and Thomas W. Feeley. "Delivering High-quality Cancer Care: The Critical Role of Quality Measurement." Healthcare: The Journal of Delivery Science and Innovation 2, no. 1 (March 2014): 53–62. (PMCID: PMC4021589.)
- 2022
- Working Paper
The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives
By: Ariel Dora Stern
For those who follow health and technology news, it is difficult to go more than a few days without reading about a compelling new application of Artificial Intelligence (AI) to health care. AI has myriad applications in medicine and its adjacent industries, with... View Details
Keywords: AI and Machine Learning; Health Care and Treatment; Governing Rules, Regulations, and Reforms; Technological Innovation; Medical Devices and Supplies Industry
Stern, Ariel Dora. "The Regulation of Medical AI: Policy Approaches, Data, and Innovation Incentives." NBER Working Paper Series, No. 30639, December 2022.
- 01 Feb 2022
- Book
Innovation Isn’t Just for Startups: How Big Companies Can Succeed
What if more managers at big corporations channeled some of the same magic that helped Tesla CEO Elon Musk and Amazon founder Jeff Bezos lead their startups to great success? Large companies are actually fertile ground for innovation; they just need to know how to... View Details
Keywords: by Lane Lambert
- 21 Apr 2009
- First Look
First Look: April 21, 2009
season. We first document relatively low levels of adoption of this new risk management technology: only 5%-10% of households purchase insurance, even though rainfall variability is overwhelmingly cited by households as the most important... View Details
Keywords: Martha Lagace
- April 2024 (Revised November 2024)
- Case
Moderna: Pioneering a People Platform to Accelerate Science Innovation
By: Tatiana Sandino, Emil Dy and Samuel Grad
Moderna was founded in 2010 to explore how messenger ribonucleic acid (mRNA) could be used to create breakthrough medicines by encoding instructions for the body to create antibodies. When Stéphane Bancel (HBS 2000) took over in 2011, he bet on the potential of this... View Details
Keywords: Disruptive Innovation; Talent and Talent Management; Selection and Staffing; AI and Machine Learning; Digital Strategy; Innovation and Management; Leadership Development; Management Practices and Processes; Management Systems; Organizational Culture; Performance Evaluation; Alignment; Employee Relationship Management; Science-Based Business; Expansion; Pharmaceutical Industry; Biotechnology Industry; United States
Sandino, Tatiana, Emil Dy, and Samuel Grad. "Moderna: Pioneering a People Platform to Accelerate Science Innovation." Harvard Business School Case 124-091, April 2024. (Revised November 2024.)
- September 2023
- Teaching Note
Roche: ESG and Access to Healthcare
By: George Serafeim
Teaching Note for HBS Case No. 123-075. In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal... View Details
- January–February 2023
- Article
Data-Driven COVID-19 Vaccine Development for Janssen
By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan
The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details
Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry
Bertsimas, Dimitris, Michael Lingzhi Li, Xinggang Liu, Jennings Xu, and Najat Khan. "Data-Driven COVID-19 Vaccine Development for Janssen." INFORMS Journal on Applied Analytics 53, no. 1 (January–February 2023): 70–84.
- 15 Mar 2024
- HBS Case
Let's Talk: Why It's Time to Stop Avoiding Taboo Topics at Work
organization’s ability to groom successors, threatening performance. “This leads many ambitious 50-year-olds to leave the company in search of better opportunities,” Wing says. Instead, companies would be wise to initiate an open dialogue about succession, job... View Details
Keywords: by Avery Forman
- 28 Jul 2008
- Research & Ideas
Making the Decision to Franchise (or not)
appears to be true when you get a new type of consumer for the same product." In the pharmaceutical industry, for example, selling medicine to both an independent general practitioner and a hospital will... View Details
- 29 May 2001
- Research & Ideas
Genomics: Can We Start Making Money Now?
predict a new world where drug treatments are customized to an individual's genetic makeup, and gene-based therapy can root out cancer and other diseases before they take hold in the body. The new science... View Details
Keywords: by Sean Silverthorne
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
by harnessing a new business model. The bold approach worked. Gilead, one of the world’s leading antiviral makers, would sell its branded Hepatitis C medicines while offering local manufacturers voluntary... View Details
- November 2022
- Teaching Note
Proximie: Using XR Technology to Create Borderless Operating Rooms
By: Ariel D. Stern, Alpana Thapar and Menna Hassan
Founded by Nadine Hachach-Haram in 2016, Proximie was a digital medicine platform that used mixed reality and a host of digital audio and visual tools to enable clinicians, proctors, and medical device company personnel to be virtually present in operating rooms (ORs),... View Details
- 28 Nov 2016
- Research & Ideas
Challenging the Belief that Liability Laws Kill Medical Device Innovation
in passing tort reform laws to limit the amount of damages patients can receive. Less attention has been paid to the effect such reforms can have on medical device innovation. Under the chilling effect of potential lawsuits, a doctor may be less willing to try View Details
- 02 Mar 2007
- What Do You Think?
What Is the Government’s Role in US Health Care?
avoidance on the part of physicians, a litigious society, and inadequate protection from it for physicians (Rowland Freeman), "defensive" medicine leading to unnecessary tests and treatments, an insurance system that is costly and... View Details
- 12 Dec 2022
- Research & Ideas
Buy-In from Black Patients Suffers When Drug Trials Don’t Include Them
Black patients and their doctors may be more open to new medications if drug trials included more Black people, new research shows. Currently, Black Americans represent just 5 percent of drug trial... View Details
- 13 Mar 2007
- First Look
First Look: March 13, 2007
of the microfinance industry and the challenges of investing in this new field of the emerging markets. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=307078 Organic Growth at Wal-Mart Harvard Business... View Details
Keywords: Martha Lagace
- 19 Nov 2014
- HBS Case
Marketing Marijuana
the United States, two new states, Alaska and Oregon, as well as the District of Columbia had legalized the recreational sale of marijuana. They joined Washington and Colorado, which legalized pot in the 2012 election, as well as two... View Details
- 07 Mar 2018
- Research & Ideas
Electronic Health Records Were Supposed to Cut Medical Costs. They Haven't.
Despite the promise that electronic health records would cut billing costs, savings have yet to materialize, according to a major new study by researchers at Harvard Business School and Duke University. “The theory was that part of... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
"It is difficult to conceive of a child as commerce," writes Harvard Business School professor Debora L. Spar in her new book, The Baby Business: How Money, Science, and Politics Drive the Commerce of Conception. In fact, baby... View Details
- 06 Dec 2016
- First Look
December 6, 2016
Harvard Business Review How Wikipedia Keeps Political Discourse from Turning Ugly By: Greenstein, Shane, and Feng Zhu Abstract—No abstract available. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=51942 November 17, 2016 View Details
Keywords: Sean Silverthorne